Infliximab: all 244 studies that test it

Page 3 of 3. Open to participants first (30), then studies with results posted, then the rest; newest registration first within each.

• Study of Two Schedules of Infliximab Maintenance Therapy in Ankylosing SpondylitisCompletedNCT00439283Phase 3
• Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic ArthritisCompletedNCT00432406Phase 4
• A Comparison of Methotrexate Alone or Combined to Infliximab or to Pulse Methylprednisolone in Early Rheumatoid Arthritis: A Magnetic Resonance Imaging StudyCompletedNCT00396747Phase 4
• Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN)WithdrawnNCT00372723Phase 2
• TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL )TerminatedNCT00368264Phase 2/3
• Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to EtanerceptCompletedNCT00317538Phase 3
• RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing VasculitidesCompletedNCT00307593Not applicable
• A Clinical Trial of Infliximab for UveitisCompletedNCT00273390Not applicable
• Infliximab Plus Methotrexate for the Treatment of Rheumatoid ArthritisCompletedNCT00269867Phase 3
• An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Crohn's DiseaseCompletedNCT00269854Phase 2/3
• An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Fistulizing Crohn's DiseaseCompletedNCT00269841Phase 3
• Treatment of Perianal Crohn's Disease, Combining Medical and Surgical Treatment.TerminatedNCT00252369Not applicable
• The Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) ProtocolCompletedNCT00246064Phase 4
• Effects of Infliximab (Remicade) on Fat Free Mass in Patients With Moderate to Severe COPD Suffering From CachexiaCompletedNCT00244192Phase 2
• Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing SpondylitisStatus unknownNCT00237419Not applicable
• A Safety and Efficacy Study for Infliximab (Remicade) With Methotrexate in Patients With Early Rheumatoid ArthritisCompletedNCT00236028Phase 3
• A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Plaque Type PsoriasisCompletedNCT00230529Phase 2
• GVH 022P: Study Using Anti Tumor Necrosis Factor Antibody (Infliximab) for Treatment of Acute Graft Versus Host DiseaseCompletedNCT00228839Phase 1
• Comparison of Adalimumab and Infliximab Treatment of Rheumatoid ArthritisStatus unknownNCT00216177Phase 4
• A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis.CompletedNCT00207701Phase 3
• A Study of the Safety and Efficacy of Infliximab (Remicade) in Pediatric Patients With Crohn's DiseaseCompletedNCT00207675Phase 3
• Evaluation of Low Dose Infliximab in Ankylosing Spondylitis (Study P04352)CompletedNCT00202865Phase 3
• A Placebo-Controlled, Double-Blinded, Randomized Trial of Remicade in Korean Patients With Rheumatoid Arthritis Despite Methotrexate (Study P04280)(COMPLETED)CompletedNCT00202852Phase 3
• Infliximab for the Prevention of Graft-versus-Host Disease Following Allogenic Hematopoietic Stem Cell TransplantationCompletedNCT00201799Phase 2
• Islet Transplantation Using Campath-1H and Infliximab InductionCompletedNCT00175266Phase 2
• Infliximab in Treating Cancer-Related Fatigue in Postmenopausal Women Who Have Undergone Treatment for Breast CancerTerminatedNCT00112749Phase 2
• A Study of the Safety and Effectiveness of Infliximab in Patients With Plaque-type PsoriasisCompletedNCT00106847Phase 3
• A Study of the Safety and Efficacy of Infliximab in Patients With PsoriasisCompletedNCT00106834Phase 3
• A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Ulcerative ColitisCompletedNCT00096655Phase 3
• A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Giant Cell ArteritisTerminatedNCT00076726Phase 2
• Infliximab to Treat Non-Infectious ScleritisCompletedNCT00075075Phase 1
• Infliximab in Treating Patients With Myelodysplastic SyndromeCompletedNCT00074074Phase 2
• A Study of Infliximab in Patients With SarcoidosisCompletedNCT00073437Phase 3
• A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related CachexiaCompletedNCT00060502Phase 2
• A Study of Safety and Efficacy of Infliximab (Remicade) in Patients With COPDCompletedNCT00056264Phase 3
• A Study of the Safety and Effectiveness of Infliximab for the Treatment of Psoriatic ArthritisCompletedNCT00051623Phase 3
• Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)CompletedNCT00040885Phase 3
• A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative ColitisCompletedNCT00036439Phase 3
• A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Rheumatoid Arthritis.CompletedNCT00036387Phase 3
• A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Juvenile Rheumatoid ArthritisCompletedNCT00036374Phase 3
• Infliximab (Remicade ) to Treat Dermatomyositis and PolymyositisCompletedNCT00033891Phase 2
• Infliximab to Treat Children With Juvenile Rheumatoid ArthritisTerminatedNCT00029042Phase 2
• Infliximab for the Treatment of Early Rheumatoid ArthritisCompletedNCT00006292Phase 2
• Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's DiseaseCompletedNCT00004941Phase 3

← Infliximab overview